| Ytd | 51.00% | |
| 1y | 148.77% |
| Open | 3.03 | Prev Close | 3.06 | Low | 3.01 | High | 3.10 | Mkt Cap | 252.65M |
| Vol | 41.38K | Avg Vol | 1.01M | EPS | -1.18 | P/E | -2.59 | Forward P/E | -1.20 |
| Beta | 0.55 | Short Ratio | 4.69 | Inst. Own | 8.05% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-12 | 50-d Avg | 4.11 | 200-d Avg | 3.40 | 1yr Est | 10.50 |
Health care sector oversold - buying opportunities in undervalued companies. RSI compares stock stre
Opus Genetics, Inc. (NASDAQ:IRD) (the "Company", "Opus Genetics" or "Opus"),
Opus Genetics has received the meeting minutes from the Type B meeting confirming several key elemen
Opus Genetics, Inc. (NASDAQ:IRD) (the "Company" or "Opus Genetics"), a clinical-stag
Top Wall Street analysts changed outlook on top names. See all changes, including upgrades and downg